NutriBand (NTRB) Intangibles (2017 - 2026)
NutriBand (NTRB) posted Intangibles of $838462.0 for Q2 2026, little changed sequentially from $838462.0 in Q1 2026, and up 240.94% YoY from $245926.0 in Q2 2025.
NutriBand (NTRB) Intangibles (2017 - 2026) Analysis & Trends
NutriBand has reported Intangibles for 10 years, with the latest figure at $838462.0 in Q2 2026.
- Quarterly Intangibles rose 240.94% year-over-year to $838462.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $838462.0 (up 240.94% YoY) and the FY2026 annual result came in at $838462.0, up 221.14% from the prior year.
- Intangibles was little changed at $838462.0 in Q2 2026 per NTRB's latest filing, from $838462.0 in the prior quarter.
- Over five years, Intangibles peaked at $1.1 million in Q3 2024 and troughed at $230760.0 in Q3 2025.
- A 5-year average of $737029.3 and a median of $794574.0 in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2025 and 2026: Intangibles slumped 79.61% in 2025, then soared 240.94% in 2026.
- Over 5 years, Intangibles stood at $808718.0 in 2022, then retreated by 13.99% to $695568.0 in 2023, then jumped by 62.67% to $1.1 million in 2024, then slipped by 25.9% to $838462.0 in 2025, then changed by 0.0% to $838462.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $838462.0, $838462.0, and $838462.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | - |
| 10 | NutriBand | 53.43 Mn | 49.42 Mn | 196,801.00 | 838,462.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 838,462.00 |
| Jan 31, 2026 | 838,462.00 |
| Oct 31, 2025 | 838,462.00 |
| Jul 31, 2025 | 230,760.00 |
| Apr 30, 2025 | 245,926.00 |
| Jan 31, 2025 | 261,092.00 |
| Oct 31, 2024 | 1.13 Mn |
| Jul 31, 2024 | 1.13 Mn |
| Apr 30, 2024 | 638,993.00 |
| Jan 31, 2024 | 667,280.00 |
| Oct 31, 2023 | 695,568.00 |
| Jul 31, 2023 | 723,855.00 |
| Apr 30, 2023 | 752,143.00 |
| Jan 31, 2023 | 780,430.00 |
| Oct 31, 2022 | 808,718.00 |
| Jul 31, 2022 | 862,004.00 |
| Apr 30, 2022 | 894,459.00 |
| Jan 31, 2022 | 926,913.00 |
| Oct 31, 2021 | 959,367.00 |
| Jul 31, 2021 | 991,821.00 |